Klassen Preston

President & CEO, DirectorMetacrine, Inc. (MTCR) · full profile →Form 4 · filed Jan 27, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$156K
Net Open-Market Flow
-$156K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 26, 2023Sell(S)381K$0.41$156K542K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-005271) within minutes of acceptance. Every field above traces to the original document. Verify it directly: